Urgent Call for pharmacists to participate in vaccine safety pilot

The Actively Monitoring the Safety of Immunisation in Community Pharmacies in Western Australia (AIM-CP) study is proudly funded by the J M O’Hara Research Fund

Pharmacists play a crucial role in administering vaccinations in the community, and that role is more important than ever this year. We are urgently calling for Western Australian Pharmacies to participate in a pilot study that will implement and evaluate SmartVax as a tool to monitor vaccine safety following immunisation in pharmacy. This study will monitor safety of all vaccinations in 2020 and lay the foundation for future COVID-19 vaccine safety monitoring. There is no cost to participate. Setup time is only 10-15 minutes with no additional work for the pharmacy or team after that. Patients are sent a pharmacy branded SMS after immunisation enquiring if they had any reactions.  If they have had a reaction, a follow up SMS will be sent to check if the reaction was medically attended followed by a smartphone questionnaire to get further information. Pharmacists will be notified of any significant reaction to enable follow up with patients.

Full details are available in the Site Information.

To participate in the SmartVax pilot, please contact Dr Sandra Salter: sandra.salter@uwa.edu.au

SmartVax in Pharmacy Survey

A separate component of the study seeks to identify information about how vaccination services are currently provided and recorded from community pharmacy in WA including adverse event recording.  To complete the click on the following link:

SmartVax in Pharmacy Survey.


For more information on the survey or study participation: Dr Sandra Salter: sandra.salter@uwa.edu.au

SmartVax: http://www.smartvax.com.au

Jocelyn Sisson